| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/07/2004 | WO2004055157A3 Methods of using vectors to treat metabolic disorders |
| 10/07/2004 | WO2004050881A3 A plant transcription factor that is involved in sugar signalling |
| 10/07/2004 | WO2004048402B1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 10/07/2004 | WO2004045517A3 Method for the diagnosis and treatment of vascular disease |
| 10/07/2004 | WO2004044159A3 Receptors and membrane-associated proteins |
| 10/07/2004 | WO2004044132A3 Modified oligonucleotides for use in rna interference |
| 10/07/2004 | WO2004035626A3 Alpha macroglobulin protein family members |
| 10/07/2004 | WO2004033640A3 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 10/07/2004 | WO2004024880A3 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 10/07/2004 | WO2004020623B1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 10/07/2004 | WO2004020585B1 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 10/07/2004 | WO2004015060A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/07/2004 | WO2004014112A3 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 10/07/2004 | WO2004011597A3 Primary nucleotide sequence of the agrotis segetum granulosis viris (asgv), its use in a system to dicover insecticides, and use in prevention and control of agrotis segetum insect pest |
| 10/07/2004 | WO2004007709A3 Production of polyketides |
| 10/07/2004 | WO2004007678B1 Codon optimized synthetic plasmids |
| 10/07/2004 | WO2003106648A3 Compositions and methods relating to breast specific genes and proteins |
| 10/07/2004 | WO2003106633A3 Method to increase isoflavonoid levels in plants and plants producing increased levels of isoflavonoids |
| 10/07/2004 | WO2003103600A3 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003097662A8 Antisense modulation of apolipoprotein b expression |
| 10/07/2004 | WO2003091446A3 Multi-functional microarrays and methods |
| 10/07/2004 | WO2003083059A3 Mcp-1 mutant proteins, antibodies, compositions, methods and uses |
| 10/07/2004 | WO2003077848A3 Jagged 2 inhibitors for inducing apoptosis |
| 10/07/2004 | WO2003076463A8 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance |
| 10/07/2004 | WO2003072603A9 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2003070768A3 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 10/07/2004 | WO2003066893A8 Methods for specific rapid detection of pathogenic food-relevant bacteria |
| 10/07/2004 | WO2003066818A3 Secretion, transcription and sporulation genes in bacillus clausii |
| 10/07/2004 | WO2003062420A8 Molecular libraries |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2003029431A3 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 10/07/2004 | WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | WO2002070647A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 10/07/2004 | WO2002067771A3 Chemokine receptors and disease |
| 10/07/2004 | US20040199947 Nucleotide sequences coding enzymatic polypeptides associated with plant saccharose metabolism for use in transformation and propagation of sugar beets with improved storage stability; tissue engineering |
| 10/07/2004 | US20040199946 Protein kinase stress-related proteins and methods of use in plants |
| 10/07/2004 | US20040199945 Preparing heavy chain binding protein microarray in plant cells via genetic transformation and gene expression; tissue engineering; diagnostic antibody microarrays |
| 10/07/2004 | US20040199944 Comprises fusion protein coding optimized transit peptide for use in the generation of herbicide resistant plants; tissue engineering |
| 10/07/2004 | US20040199943 Transgenic green coffee bean comprising galatomannans with enhanced branching; enhancing solubility and storability of coffee particles; tissue engineering |
| 10/07/2004 | US20040199942 Starch comprising high beta glucan content for enhancing dietary fiber and food processibility of grains; tissue engineering and reduction in total serum cholesterol and low density lipoproteins (LDL); preventing coronary heart disease |
| 10/07/2004 | US20040199940 Comprises nuclelotide sequences coding protein which modulates ergosterol biosynthesis for use as tool in transformation, expression and biosynthesis of steroids in plants; tissue engineering |
| 10/07/2004 | US20040199939 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 10/07/2004 | US20040199938 Using transponson activation to generate preferential phenotypes in corn; tissue engineering; plant transgenesis and improving agronomic or dietary qualities maize |
| 10/07/2004 | US20040199937 Using microparticle bombardment to transform and generate transgenic chloroplast; heterologous gene expression; generating disease and stress resistant plants; tissue engineering |
| 10/07/2004 | US20040199935 Cytoplasmic transfer to de-differentiate recipient cells |
| 10/07/2004 | US20040199934 Transgenic rodents as animal moldels for modulation of b1 bradykinin receptor protein |
| 10/07/2004 | US20040198967 Expression vector comprising RNA interference sequences for use as transcription suppression tool in target gene therapy |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198959 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198690 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 10/07/2004 | US20040198689 Ribozyme sequences related to hiv resistance |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198687 Endosomolytic polymers |
| 10/07/2004 | US20040198685 For prophylaxis and therapy of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen |
| 10/07/2004 | US20040198683 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 10/07/2004 | US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) |
| 10/07/2004 | US20040198679 Use of inhibitors of expression or activity of p8/com1 for treating tumors |
| 10/07/2004 | US20040198659 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198656 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 10/07/2004 | US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs |
| 10/07/2004 | US20040198648 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 10/07/2004 | US20040198640 Exposing double stranded polynucleotide comprised of a sense strand and an antisense strand to target nucleic acid and wherein at least one strand comprises at least one orthoester modified nucleotide; medical diagnosis; genetic engineering |
| 10/07/2004 | US20040197918 Epression vector coding replication protein for transformation and generation of coryneform bacterium that can grow at an elevated temperature; fermentation of amino acid sequences for use in cosmetics, nutrients and medicines |
| 10/07/2004 | US20040197917 AXMI-014, delta-endotoxin gene and methods for its use |
| 10/07/2004 | US20040197916 AXMI-004, a delta-endotoxin gene and methods for its use |
| 10/07/2004 | US20040197915 Transgenic tobacco expressing phosphoenol pyruvate carboxylase of poaceae; enhanced light processing capabilites |
| 10/07/2004 | US20040197914 Viral delivery systems and related manufacture and use |
| 10/07/2004 | US20040197913 Enhancing viral insertion into mammalian genomes via inhibition of replication/repair proteins; gene therapy and heterologus gene expression |
| 10/07/2004 | US20040197911 Novel 88 phage vectors |
| 10/07/2004 | US20040197910 Gene regulation in transgenic animals using a transposon-based vector |
| 10/07/2004 | US20040197906 Oligonucleotides for controlling protein kinase a (PKA)gene expression for use in treatment of metabolic, developmental and cell proliferative disorders; gene expression inhibition |
| 10/07/2004 | US20040197902 Transgenic mammalian endothelial progenitor cells for use in the treatment of vision defects; gene therapy and neovascularization |
| 10/07/2004 | US20040197896 Identifying genes associated with mycobacterial viability and virulence for use in designing modulators for treatment and prevention of infection |
| 10/07/2004 | US20040197895 Packaging lines for generation of high titers or recombinant aav vectors |
| 10/07/2004 | US20040197894 Comprises proteolytic polypeptide with enhanced wash performance, thermal stability, storage stability and catalytic activity for improving laundering and diswashing detergents |
| 10/07/2004 | US20040197890 Comprises heat resistant enzymatic polypeptide for bioremediation of plant biomass and pollution control; reuse |
| 10/07/2004 | US20040197889 cell free hepatitis b virus transcription/translation in escherichia plasmid; enzyme inhibitors; mimetics; viricides; shelf life |
| 10/07/2004 | US20040197883 Apparatus and method for electroporation of biological samples |
| 10/07/2004 | US20040197878 Process for the fermentative preparation of d-pantothenic acid and/or salts thereof |
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof |
| 10/07/2004 | US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy |
| 10/07/2004 | US20040197872 can be used in single or dual purpose and porcine reproductive respiratory syndrome virus vector vaccines; genetic engineering |
| 10/07/2004 | US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering |
| 10/07/2004 | US20040197866 library can be used to select and screen for new monoclonal antibodies, and to optimize; genetic engineering |
| 10/07/2004 | US20040197864 Derivatives of magainin and methods of production thereof |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197861 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 10/07/2004 | US20040197860 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 10/07/2004 | US20040197859 useful for treatment of migraine headaches/prophylaxis, menopausal hot flashes, chronic tension type headache, cluster headache, neurogenic or chronic inflammation, gastrointestinal disorders, type 2 diabetes and cardiovascular disorders |
| 10/07/2004 | US20040197857 plasmid is constructed so as to express a fused protein of a sugar chain-binding protein domain with a desired protein |
| 10/07/2004 | US20040197855 Test system for determining gene toxicities |
| 10/07/2004 | US20040197854 nucleic acid construct integrates into the host genome at a locus not within the DNA sequence of interest to produce a mutant cell |